Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05919342 · ClinicalTrials.gov registry record · NA
Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"
A NA study of Heart Failure and Cardiovascular Diseases, sponsored by NHS Greater Glasgow and Clyde.
- Recruiting
- Registry status
- NA
- Development phase
- 3,904
- Enrollment target
- 7
- Study locations
NCT05919342: Recruiting NA study of Heart Failure and Cardiovascular Diseases, sponsored by NHS Greater Glasgow and Clyde.
NCT05919342 is a NA study of Heart Failure and Cardiovascular Diseases that is actively recruiting participants, run by NHS Greater Glasgow and Clyde. The registered enrollment target is 3,904 participants, above the 2,039-participant average among 397 other Heart Failure trials with a reported enrollment target (91% higher). The trial reports 7 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05919342, a NA study of Heart Failure and Cardiovascular Diseases, is actively recruiting participants, sponsored by NHS Greater Glasgow and Clyde.
- RECRUITING
- Registry status
- NA
- Development phase
- 3,904 participants
- Enrollment target
- 7
- Study locations
Study Summary
This is an international prospective, multicentre, unblinded, randomised-controlled trial. The primary aim is to assess a targeted screening strategy to detect undiagnosed heart failure in high-risk patients.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST NT-proBNP
Study Locations (7)
Other
- Rigshospitalet, Copenhagen University Hospital - Copenhagen
- Karolinska University Hospital - Stockholm
- Uppsala University - Uppsala
Ohio
- Cleveland Clinic - Cleveland
British Columbia
- University of British Columbia - Vancouver
Quebec
- University of Montreal - Montreal
Scotland
- University of Glasgow - Glasgow
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,904 participants |
| Start Date | 2022-12-22 |
| Est. Completion | 2032-12-21 |
| Phase | NA |
What NCT05919342 shows while recruiting
NCT05919342 is an interventional study that assigns participants to a tested intervention. Its 3,904 participants enrollment target places it among the larger protocols in the corpus, above the 2,039-participant average among 397 other Heart Failure trials with a reported enrollment target (91% higher).
The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which NT-proBNP is the first listed.
NCT05919342 lists 7 locations in 5 states (Other, Ohio, British Columbia).
Frequently Asked Questions
What is clinical trial NCT05919342 about?
NCT05919342 is a clinical study titled "Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"". This is an international prospective, multicentre, unblinded, randomised-controlled trial. The primary aim is to assess a targeted screening strategy to detect undiagnosed heart failure in high-risk patients.
What is the current status of trial NCT05919342?
This trial is currently recruiting. It is a NA study. The enrollment target is 3,904 participants. The study started on 2022-12-22. Estimated completion is 2032-12-21.
What conditions does trial NCT05919342 study?
This clinical trial studies the following conditions: Heart Failure, Cardiovascular Diseases.
What interventions are being tested in trial NCT05919342?
The interventions under investigation include: NT-proBNP (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05919342?
This trial is sponsored by NHS Greater Glasgow and Clyde, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05919342 being conducted?
This trial has 7 study locations across Ohio, British Columbia, Quebec, Scotland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05919342's enrollment target sits among peer trials
3,904 30th of 397 higher than 368 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03936335 · 3,930 participants
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)
- NCT07087613 · 3,850 participants
Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG
- NCT05879926 · 3,960 participants · Phase 3
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
- NCT00227253 · 4,000 participants
Chromosome 18 Clinical Research Center
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI